首页> JAAD case reports> Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19.

Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19.

导出 LinkOut

翻译打印收藏纠错

第一作者： Netana H,Markovitz

第一单位： University of Michigan Medical School, Ann Arbor, Michigan.

作者： Netana H,Markovitz ^[1] ; Elisabeth,Pedersen ^[2] ; Dana L,Sachs ^[2] ; Scott C,Bresler ^[3]

作者单位： University of Michigan Medical School, Ann Arbor, Michigan. ^[1] Michigan Medicine Department of Dermatology, Ann Arbor, Michigan. ^[2] Michigan Medicine Department of Dermatology, Ann Arbor, Michigan.;Michigan Medicine Department of Pathology, Ann Arbor, Michigan. ^[3]

关键词 COVID-19 antiviral FDE, fixed drug eruption REGN-COV2 REGN-COV2, casirivimab/imdevimab casirivimab drug eruption drug reaction imdevimab lichenoid reaction

DOI 10.1016/j.jdcr.2022.07.007

PMID 35845347

发布时间 2022-09-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JAAD case reports

2022年27卷

156-158页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

JAAD case reports

2022年27卷

156-158页

检索历史清除

Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19.

JAAD case reports

相似文献

同项目论文

JAAD case reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19.

JAAD case reports

相似文献

同项目论文

JAAD case reports

相关期刊

检索历史清除